Stay updated on Nivolumab Combinations in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s displayed software/revision version is updated from v3.5.2 to v3.5.3. This reflects a site/version change rather than an update to the trial’s record details.
    Difference
    0.0%
    Check dated 2026-04-24T06:14:50.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:44:58.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:57:25.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history and revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T00:28:13.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    New Revision: v3.4.2 was added and the funding-status notice (and Revision: v3.4.1) was removed, reflecting routine site maintenance. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:56:41.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a site-wide funding notice and updated the site revision from v3.4.0 to v3.4.1. No study record data or core content were changed.
    Difference
    0.4%
    Check dated 2026-02-04T10:53:22.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR+ NSCLC Clinical Trial page.